Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
West Coast Retina Medical Group is a premier ophthalmology practice specializing in the diagnosis and treatment of vitreoretinal diseases, including macular degeneration, diabetic retinopathy, and retinal detachment. Established in 1974 and headquartered in San Francisco, the group operates multiple clinics across Northern California and is recognized for its advanced surgical expertise and robust clinical research program. As a leading clinical trial site, West Coast Retina participates in numerous multicenter studies for innovative therapies such as gene and cell-based treatments for retinal disorders. The practice also hosts a prestigious vitreoretinal fellowship program, contributing to the training of future specialists in the field. Their team of fellowship-trained surgeons is dedicated to providing high-quality, patient-centered care using the latest diagnostic and therapeutic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on West Coast Retina Medical Group.